Transcriptomics

Dataset Information

0

Trancsriptional profiling of B16-C10 tumors treated with PBS, oBHV or MMC+oBHV.

ABSTRACT: To explore the mechanism of action upon addition of MMC to oBHV therapy, unbiased transcriptional profiling was conducted on B16-C10 tumors treated with PBS, oBHV or MMC+oBHV harvested at day 5.

ORGANISM(S): Mus musculus

PROVIDER: GSE223637 | GEO | 2023/02/17

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics Trancsriptional profiling of B16-C10 tumors treated with PBS, oBHV or MMC+oBHV.
| PRJNA927005 | ENA
Transcriptomics Transcription profiling of Mus musculus PBS vs IL-5 trerated LLC cells, and LLC vs B16 cells at baseline conditions
2010-12-13 | E-MEXP-2490 | biostudies-arrayexpress
Transcriptomics RNA-sequencing of Mycobacterium tuberculosis treated with C10
2019-05-31 | GSE129833 | GEO
Transcriptomics Characterization of A. baumannii Mitomycin C (MMC) response
2013-11-14 | GSE44735 | GEO
Transcriptomics Characterization of A. baumannii Mitomycin C (MMC) response
2013-11-14 | E-GEOD-44735 | biostudies-arrayexpress
Transcriptomics RNA sequencing analysis of B16-F1, B16-F1R2 and B16-F1R2L
2021-07-28 | GSE150221 | GEO
Transcriptomics RNA-sequencing of hypoxic Mycobacterium tuberculosis treated with C10
2019-05-31 | GSE129830 | GEO
Transcriptomics Deinococcus radiodurans R1 Cells was treated with MMC (5 M-NM-<g/ml) : Control treated with MMC (5 M-NM-<g/ml) vs. bphPR deletion mutant treated with MMC (5 M-NM-<g/ml)
2014-07-07 | E-GEOD-59138 | biostudies-arrayexpress
Transcriptomics Deinococcus radiodurans R1 Cells was treated with MMC (5 μg/ml) : Control treated with MMC (5 μg/ml) vs. bphPR deletion mutant treated with MMC (5 μg/ml)
2014-07-07 | GSE59138 | GEO
Transcriptomics NanoString Analysis of Gene Expression in B16.F10 Tumors Treated with the cGAS Activator, NanoISD
2021-09-01 | GSE183144 | GEO